Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

34.79
+1.233.68%
Volume:12.51K
Turnover:437.60K
Market Cap:212.77M
PE:-9.95
High:36.11
Open:34.60
Low:33.54
Close:33.56
Loading ...

Monopar Therapeutics Initiated at Buy by Chardan Capital

Dow Jones
·
23 Jun

Monopar Therapeutics Inc. Conducted Annual Stockholder Meeting

Reuters
·
23 Jun

Monopar Therapeutics initiated with a Buy at Chardan

TIPRANKS
·
23 Jun

Monopar Therapeutics, EDNOC announce EAP for MNPR-101-Zr, MNPR-101-Lu

TIPRANKS
·
11 Jun

Monopar and Ednoc Announce Expanded Access Program for Mnpr-101-Zr and Mnpr-101-Lu in Advanced Cancers

THOMSON REUTERS
·
11 Jun

Monopar Therapeutics initiated with a Buy at Lucid Capital

TIPRANKS
·
05 Jun

Monopar Therapeutics to Join Russell Indexes

MT Newswires Live
·
03 Jun

Piper Sandler Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
19 May

Monopar Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Monopar Therapeutics Q1 EPS $(0.38) Beats $(0.68) Estimate

Benzinga
·
13 May

Monopar Therapeutics Q1 2025 Results: Net Loss Increases to $2.6M, EPS at $0.38

Reuters
·
13 May

Press Release: Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

Dow Jones
·
13 May

Monopar Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview

Reuters
·
07 May

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025

Insider Monkey
·
30 Apr

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

GlobeNewswire
·
29 Apr

Major Shareholder Sells Big Chunk of Monopar Therapeutics Stock!

TIPRANKS
·
05 Apr

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
02 Apr

JonesTrading downgrades Monopar Therapeutics Inc (MNPR) to a Hold

TIPRANKS
·
02 Apr

Monopar Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

Monopar Therapeutics Q4 EPS $(2.23) Down From $(0.60) YoY

Benzinga
·
31 Mar